Booster dose of Omicron-compatible vaccine, likely to boost immunity = European Medicines Agency

Omicron-compatible vaccine

Health authorities, including the European Pharmaceutical Agency (EMA) of the European Union (EU), used a vaccine modified for the Omicron variant of the new coronavirus as a booster vaccination (additional vaccination) on the 1st. If so, the immune effect may be enhanced, he said.

The view expressed by EMA is for a new corona vaccine that uses “messenger RNA (mRNA)” technology. Pfizer and Moderna, which manufacture mRNA vaccines, have begun testing vaccines for Omicron mutants.

On June 28, the US Food and Drug Administration’s (FDA) advisory board recommended that the new coronavirus vaccine be boosted (additional) this fall to accommodate the Omicron variant.

Thomas Williams

Thomas Williams writes related to the Trending news Category. He manages to cover anything thrown at him owing to his natural inclination towards Business. Thomas is our freelance contributor. Thomas is responsible for covering developments in Trending news related to finance and the world market.

Email: [email protected]

Address: 1122 North Cottage Grove, Miles City, MT 59301, USA

Contact number: 618-680-8300

Leave a Reply

Your email address will not be published. Required fields are marked *